Race, Trust Affect Level of Migraine Treatment

Article

Undertreatment of migraine, while not limited to any particular racial or ethnic group, may be especially pervasive among black persons, according to researchers from Saint Louis University.

Undertreatment of migraine, while not limited to any particular racial or ethnic group, may be especially pervasive among black persons, according to researchers from Saint Louis University.

Robert A. Nicholson, PhD, and colleagues in the Department of Family Medicine surveyed 313 adults with headache who were recruited from primary care waiting rooms but were not necessarily seeing the physician for headache treatment.More than one third of the study participants experienced migraine and reported moderate to severe headache-related disability. Fewer than 15% reported having a migraine-specific medication prescribed for them; however, white patients were more than twice as likely as black patients to have received a prescription.

Black patients were also less likely than white patients to have seen a physician for migraine treatment, and reported significantly lower levels of trust in the medical community and of patient-physician communication. Those with lower levels of trust and communication were less likely to have seen a physician for migraine symptoms or to have received medication to treat those symptoms.

The citation for this study is: Nicholson RA, Rooney M, Vo K, et al. Migraine care among different ethnicities: do disparities exist? Headache. 2006;46:754-765.
-Jordana Bieze Foster

Related Videos
Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA
Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA
Chelsie Monroe, MSN, APN, PMHNP-BC, and Karl Doghramji, MD, FAASM, DFAPA
Video 8 - "Treatment Augmentation in a Patient with Narcolepsy and ADHD"
Video 7 - "Complex Case of a 23-Year-Old Male College Student Suffering From Narcolepsy Symptoms"
Video 6 - "Patient-Centered Approach: Adapting Narcolepsy Treatments to Address Adverse Events and Mitigate Misuse Risks"
Video 5 - "Clinical Treatment Strategies for a Patient Suffering from EDS and Hypnagogic Hallucinations"
Video 2 - "Narcolepsy Evaluation, Management, and Treatment Considerations"
Video 2 - "Diagnostic Practices for Narcolepsy"
© 2024 MJH Life Sciences

All rights reserved.